[Susceptibilities of glucose non-fermentative gram-negative bacilli to antibiotics]. 1994

Y Tabe, and J Igari
Department of Clinical Pathology, Juntendo University, School of Medicine.

Glucose non-fermentative Gram-negative bacilli are important nosocomial pathogens. This study concerned with susceptibilities to antibacterial agents of strains of Glucose non-fermentative Gram-negative bacilli that were isolated from cultures of clinical materials at 123 hospital laboratories throughout Japan from September to December of 1991. The tests for susceptibilities were performed according to the disk dilution method recommended by NCCLS. The following bacteria were tested: Pseudomonas aeruginosa, Pseudomonas cepacia, Acinetobacter calcoaceticus, Alcaligenes spp., Alcaligenes xylosoxidans, Flavobacterium spp. and Xanthomonas maltophilia. The antibacterial agents tested were as follows: piperacillin (PIPC), ceftazidime (CAZ), aztreonam (AZT), imipenem (IPM), minocycline (MINO), gentamicin, amikacin (AMK) and ofloxacin (OFLX). 1. Eighty percent of the strains of P. aeruginosa and P. cepacia were sensitive to CAZ. More than ninety percent of the strains of A. calcoaceticus were sensitive to IPM, MINO, OFLX. To PIPC and IPM, about eighty percent of the strains of Alcaligenes spp. and A. xylosoxidans were sensitive. The strains of Flavobacterium spp. and X. maltophilia showed high sensitivities to MINO. 2. Annual changes in antimicrobial susceptibility patterns over 4 years (1988-1991) show that there has been a gradual increase in sensitive strains of P. aeruginosa to PIPC, CAZ and AMK. Sensitive strains of P. cepacia to AZT, IPM and MINO, and A. calcoaceticus to CAZ and MINO also have gradually increased. No yearly changes were observed in high sensitivity to MINO of the strains of Flavobacterium spp. and X. maltophilia.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Y Tabe, and J Igari
March 2003, QJM : monthly journal of the Association of Physicians,
Y Tabe, and J Igari
January 1999, Enfermedades infecciosas y microbiologia clinica,
Y Tabe, and J Igari
January 1982, Giornale di batteriologia, virologia ed immunologia,
Y Tabe, and J Igari
January 1975, Nihon saikingaku zasshi. Japanese journal of bacteriology,
Y Tabe, and J Igari
January 2022, Frontiers in cellular and infection microbiology,
Y Tabe, and J Igari
May 2007, International journal of antimicrobial agents,
Y Tabe, and J Igari
June 1982, European journal of clinical microbiology,
Y Tabe, and J Igari
May 2004, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!